Mill Creek Capital Advisors, LLC Context Therapeutics Inc. Transaction History
Mill Creek Capital Advisors, LLC
- $3.88 Billion
- Q2 2024
A detailed history of Mill Creek Capital Advisors, LLC transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Mill Creek Capital Advisors, LLC holds 104,631 shares of CNTX stock, worth $238,558. This represents 0.01% of its overall portfolio holdings.
Number of Shares
104,631
Previous 104,631
-0.0%
Holding current value
$238,558
Previous $144,000
45.14%
% of portfolio
0.01%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CNTX
# of Institutions
37Shares Held
57.2MCall Options Held
0Put Options Held
0-
Deep Track Capital, LP Greenwich, CT7.42MShares$16.9 Million0.49% of portfolio
-
Avidity Partners Management LP Dallas, TX7.42MShares$16.9 Million0.73% of portfolio
-
Great Point Partners LLC Greenwich, CT7.42MShares$16.9 Million3.93% of portfolio
-
Nextech Invest Ag7.42MShares$16.9 Million2.8% of portfolio
-
Blue Owl Capital Holdings LP New York, NY5.16MShares$11.8 Million4.29% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $36.4M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...